微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 12.13% | 32.71% | 33.59% | 17/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 9.08% | 10.06% | 174.32% | 12/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.31% | 46.46% | -70.94% | 25/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.39% | -33.04% | 24.62% | 25/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 9.14% | -20.1% | 10.79% | 28/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 8.25% | -3.28% | 265.04% | 12/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.26% | 8.65% | -86.71% | 54/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 17.01% | 1769.23% | 48.69% | 13/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.44% | 30.3% | 34.11% | 24/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.53% | 220.68% | 310.1% | 21/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.08% | -45.83% | 128.57% | 57/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 0.91% | -93.36% | -89.64% | 111/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 8.78% | -37.95% | 230.08% | 46/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.66% | -70.77% | -30.73% | 86/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.84% | -0.52% | -71.97% | 25/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 13.7% | 42.41% | -3.18% | 37/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 14.15% | 22.83% | 55.49% | 18/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.1% | 45.83% | 135.75% | 25/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.86% | 17.68% | -59.88% | 23/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 9.62% | 294.26% | -16.49% | 61/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 11.52% | 122.39% | 84.62% | 23/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.24% | 52.57% | 90.24% | 39/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.28% | 0.61% | 34.43% | 33/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 2.44% | -81.3% | -52.9% | 108/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.18% | -50.57% | 26.65% | 67/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.09% | -26.96% | 25.46% | 56/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.26% | 3.82% | -75.02% | 25/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 13.05% | 13.08% | 24.52% | 31/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.48% | 2.95% | 87.14% | 24/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.6% | -6.04% | 78.34% | 38/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.14% | -5.71% | -72.79% | 24/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.54% | -5.33% | 13.36% | 45/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 10.18% | 2% | 70.81% | 23/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 5.96% | -10.38% | 78.98% | 36/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.33% | 8.47% | -72.68% | 23/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 12.19% | 49.75% | 22.14% | 43/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 9.98% | 49.85% | 50.08% | 26/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 6.65% | 75.93% | 116.61% | 25/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 3.07% | 100.65% | -62.29% | 29/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |